Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bartłomiej Perek is active.

Publication


Featured researches published by Bartłomiej Perek.


Histochemistry and Cell Biology | 2013

CD68 expression in aortocoronary saphenous vein bypass grafts

Agnieszka Malinska; Bartłomiej Perek; Piotr Buczkowski; Katarzyna Kowalska; Danuta Ostalska-Nowicka; Wojciech Witkiewicz; Michał Nowicki

Atherosclerosis commonly affects the arteries harvested from patients 70xa0years of age or older. Saphenous vein grafts appear to maintain a higher patency rate after coronary artery bypass grafting in these subjects. The infiltration of macrophages is an early step in saphenous vein graft atherosclerosis; however, little is known regarding the underlying mechanisms of infiltration. The objective of the present report is to evaluate the presence of CD68-positive cells in the saphenous vein wall and correlate initial CD68-positive infiltration to specific clinical and biochemical parameters and the graft patency rate as estimated in patients undergoing coronary artery bypass grafting. A total of 309 patients were allocated into two groups: A1 patients, who were between 50 and 70xa0years of age, and A2 patients, who were 70xa0years or older at the time of vein harvesting. CD68 expression was evaluated by immunohistochemistry. There were no significant differences between A1 and A2 patients regarding macrophage expression within any of the analyzed vascular regions. Saphenous vein macrophages were never present in the tunica intima unless they were also expressed in the media or the adventitia. The patients with CD68-positive cells in the tunica intima had a significantly higher number of bypass stenoses when compared with the subjects who did not have CD68-positive cells in this layer. These findings suggest that the CD68-positive cells (those that have not yet developed into foam cells) present in the intima of saphenous vein grafts might serve as a very early marker of graft occlusion.


Vascular Pharmacology | 2017

Platelets redox balance assessment: Current evidence and methodological considerations

Anna Komosa; Piotr Rzymski; Bartłomiej Perek; Mariola Ropacka-Lesiak; Maciej Lesiak; Jolanta M. Siller-Matula; Barbara Poniedziałek

Altered function of platelets can lead to cardiovascular complications in numerous disorders. Various studies aimed to investigate mechanisms triggering platelets activation cascade show a significant role of reactive oxygen species (ROS) in this matter. Moreover, ROS are known causal factor of oxidative stress that can result in DNA, lipid and protein damage. This review aims to comprehensively present the variety of methods that are potentially useful in assessment of platelets redox balance, such as intracellular concentration of particular ROS, activity of antioxidant enzymes, reduced/oxidized glutathione ratio, level of lipid peroxidation, Cu/Zn ratio, and molecular oxygen consumption. They may help to establish the platelet-related etiological factors in different disorders and to evaluate the antiplatelet therapies. The advantages and limitations of these methods are also discussed. The present paper highlights that clinicians may benefit from implementation of such tools and further encourages developing interdisciplinary evidence-based practice.


European Journal of Heart Failure | 2017

Safety, feasibility and effectiveness of first in‐human administration of muscle‐derived stem/progenitor cells modified with connexin‐43 gene for treatment of advanced chronic heart failure

Adrian Gwizdała; Natalia Rozwadowska; Tomasz Kolanowski; Agnieszka Malcher; Aleksandra Ciepłucha; Bartłomiej Perek; Wojciech Seniuk; Ewa Straburzyńska-Migaj; Zofia Oko-Sarnowska; Witold Cholewinski; Michał Michalak; Stefan Grajek; Maciej Kurpisz

To assess the safety and efficacy of transendocardial delivery of muscle‐derived stem/progenitor cells with connexin‐43 overexpression (Cx‐43‐MDS/PC) in advanced heart failure (HF).


Cardiology Journal | 2013

Cytokeratin 8 in venous grafts: A factor of unfavorable long-term prognosis in coronary artery bypass grafting patients

Bartłomiej Perek; Agnieszka Malinska; Danuta Ostalska-Nowicka; Mateusz Puślecki; Marcin Ligowski; Marcin Misterski; Maciej Zabel; Marek Jemielity; Michał Nowicki

BACKGROUNDnSmooth muscle cells, present in the saphenous vein (SV) tunica media, may contribute to late occlusion of venous aortocoronary grafts. The aim of present study was to evaluate expression of selected cytoskeletal proteins in tunica media of SV grafts obtained from patients undergoing coronary artery bypass grafting (CABG) and correlate procured results to late venous graft failure observed in these patients.nnnMETHODSnThe study involved 218 patients (mean age of 62.5 ± 8.7 years) who underwent primary isolated CABG with the use of at least one venous aortocoronary bypass graft. Expressions of alpha-smooth muscle actin, smooth muscle-myosin heavy chain, calponin and cytokeratin 8 in SV wall were estimated by means of immunohistochemistry. The primary clinical endpoint was defined as the presence of any coronary artery disease (CAD) progression symptom while angiographic one as significant stenosis in the venous graft.nnnRESULTSnThirty-eight (18.1%) patients have reached the primary clinical endpoint. Freedom from clinical CAD deterioration was 0.95 ± 0.02, 0.87 ± 0.03 and 0.83 ± 0.04, for 12-, 24-,36-month follow-up, respectively. Forty-four study participants have reached the angiographic endpoint. Multivariate logistic regression analysis revealed an increased expression of cytokeratin 8 accompanied by calponin under expression in SV tunica media were independent risk factors for venous graft failure.nnnCONCLUSIONSnAn increased expression of cytokeratin 8 and weak of calponin in tunica media of SV grafts might be useful markers of unfavorable long-term prognosis in CABG patients. In the future, assessment of their expression may enable to select the most appropriate candidates for SV grafts.


CardioVascular and Interventional Radiology | 2015

Extracranial Internal Carotid Artery Dissection Treated with Self-expandable Stents: A Single-Centre Experience.

Robert Juszkat; Włodzimierz Liebert; Katarzyna Stanisławska; Tomasz Tomczyk; Jarosław Wronka; Norbert Wąsik; Bartłomiej Perek

PurposeTreatment of choice for the internal carotid artery dissection (ICAD) is anticoagulation for three to 6xa0months. Endovascular procedures may be a promising alternative for patients (pts) with haemodynamic impairment, recurrent ischaemic symptoms or symptomatic pseudoaneurysms. Thus, the purpose of this study was to evaluate the efficacy and safety of carotid artery stenting in treatment of selected pts with extracranial ICAD.MethodsThis study involved 18 symptomatic pts with the mean age of 44.6xa0±xa010.4xa0years with ICAD treated with the use of self-expandable stents. Six months after primary procedures, pts were readmitted to hospital and physical examination followed by cerebral angiography was performed. In the late follow-up period, clinical evaluations completed by duplex Doppler ultrasonography were carried out every 6xa0months and at the end of the follow-up period.ResultsNobody died and no life-threatening adverse events were observed during either the in-hospital stay or post-discharge follow-up period (median 21xa0months). Stent deployment immediately restored flow in the true lumen of ICA in all cases. However, residual blood flow through the false lumen was observed in one pt. Complete resolution of clinical symptoms was observed in 14xa0pts (78xa0%), partial improvement in 2 (11xa0%) and persistence of neurological deficit in 2 (11xa0%).ConclusionsImplantation of self-expandable stents in treatment of selected extracranial ICAD cases is safe. This method may enable us to restore immediately and usually permanently proper arterial blood flow in the ICA and in consequence lead to significant clinical improvement in the late follow-up period.


Asian Cardiovascular and Thoracic Annals | 2003

Why are the results of coronary artery bypass grafting in women worse

Bartłomiej Perek; Marek Jemielity; Wojciech Dyszkiewicz

A study was conducted to assess the early results of isolated coronary artery bypass grafting in women and to determine the risk factors for early postoperative complications. Between January 1994 and July 2001, 1,730 patients (301 women and 1,429 men) underwent isolated myocardial revascularization. Conventional bypass procedure was performed on 1,554 patients (270 female and 1,284 male) and off-pump procedure on 176 patients (31 female and 145 male). Hospital mortality was significantly higher in women than in men (5.6% versus 2.9%). Low cardiac output syndrome developed in 8.6% of women and 8.5% of men. Postoperative myocardial infarction occurred in 5.3% of women and 4.3% of men (p < 0.05). The rate of infectious complications was significantly higher in women (7.0%) than in men (5.8%). The independent risk factors for early mortality in women were left ventricular ejection fraction below 40%, left main disease, and urgent operation. The need for urgent surgery in women was also found to be a significant independent predictor of low cardiac output syndrome and postoperative myocardial infarction. In conclusion, higher hospital mortality and morbidity in women undergoing coronary surgery are partially related to the severity of coronary atherosclerosis and comorbid conditions.


Annals of Transplantation | 2014

Seizures after Heart Transplantation – Two Cases of Non-Immunosuppressant Drug Interactions in Young Patients

Tomasz Urbanowicz; Magdalena Pawłowska; Piotr Buczkowski; Bartłomiej Perek; Hanna Baszyńska-Wachowiak; Ewa Straburzyńska-Migaj; Marek Jemielity

BACKGROUNDnNeurological complications occur in 30-80% of patients following heart transplantation, and seizures account for 2-20% of these sequelae. The main risk factors are toxicity due to immunosuppression, infections, and brain lesions. We present 2 cases of grand mal type attacks that occurred on the 7th and 15th postoperative days. The origin of the attacks was an unusual interaction between 2 non-immunosuppressive drugs (metoclopramide and theophylline).nnnCASE REPORTnWe present 2 cases of seizure episodes during the early postoperative period in young heart transplant recipients (a 26-year-old female and a 33-year-old man). Grand mal type attacks occurred on the 7th and 15th postoperative day, respectively. Both patients were treated with standard triple immunosuppressive therapy including tacrolimus, mycophenolate mofetil, and steroids. Therapy with metoclopramide was started because the patients reported gastrointestinal disturbances. Theophylline was administered due to postoperative bradycardia. Serum theophylline levels were 33 and 34 mcg/ml, respectively. There were no neurological deficits noticed thereafter. The magnetic resonance imaging (MRI) was negative for stroke and central nervous system infection in both cases.nnnCONCLUSIONSnWe conclude that theophylline overdose combined with metoclopramide may provoke new-onset seizures, especially in young patients following heart transplantation.


CardioVascular and Interventional Radiology | 2011

CT-Guided Thrombin Injection to Control Rapid Expansion of Ascending Aortic False Aneurysm 15 Months After Bentall–Bono Operation

Bartłomiej Perek; Tomasz Urbanowicz; Bartosz Żabicki; Mateusz Puślecki; Robert Juszkat; Marek Jemielity

We report a case of 57-year-old man treated emergently with CT-guided local thrombin injection as the first, life-saving step for control rapid expansion of the aortic pseudoaneurysm. Fifteen months earlier, he was operated on for ascending aortic true aneurysm and coronary artery disease. Upon admission, he had an anterior thoracic wall pulsatile tumor. Due to critical status, definite surgery was postponed and thrombin was injected close to the origin of pseudoaneurysm. It controlled successfully, bleeding from the ascending aorta and enabled the patient to survive the acute phase.


Disaster and Emergency Medicine Journal | 2017

High-fidelity simulation — the first DCD-ECMO procedure in Poland

Mateusz Puslecki; Marcin Ligowski; Marek Dabrowski; Maciej Sip; Sebastian Stefaniak; Tomasz Klosiewicz; Lukasz Gasiorowski; Marek Karczewski; Tomasz Małkiewicz; Malgorzata Ladzinska; Marcin Zieliński; Aleksander Pawlak; Agata Dabrowska; Piotr Ziemak; Bartłomiej Perek; Marcin Misterski; Sławomir Katarzyński; Piotr Buczkowski; Wojciech Telec; Ilona Kiel-Puslecka; Michał Kiel; Michael Czekajlo; Marek Jemielity

Mateusz Puslecki, Marcin Ligowski, Marek Dabrowski, Maciej Sip, Sebastian Stefaniak, Tomasz Klosiewicz, Lukasz Gasiorowski, Marek Karczewski, Tomasz Malkiewicz, Malgorzata Ladzinska, Marcin Zielinski, Aleksander Pawlak, Agata Dabrowska, Piotr Ziemak, Bartlomiej Perek, Marcin Misterski, Slawomir Katarzynski, Piotr Buczkowski, Wojciech Telec, Ilona Kiel-Puslecka, Michal Kiel, Michael Czekajlo, Marek Jemielity Poznan University of Medical Sciences, Department of Cardiac Surgery and Transplantology, Clinical Hospital SKPP, Poznan, Poland Poznan University of Medical Sciences, Department of Rescue and Disaster Medicine, Poznan, Poland Polish Society of Medical Simulation, Poland Poznan University of Medical Sciences, Center for Medical Simulation, Poznan, Poland Poznan University of Medical Sciences, Department of Intensive Care and Pain Treatment, Poznan, Poland Poznan University of Medical Sciences, Department of Transplantology, General, Vascular and Plastic Surgery, Poznan, Poland Poznan University of Medical Sciences, Department of Anesthesiology and Intensive Care, Clinical Hospital H. Święcickiego, Poznan, Poland Voivodeship Emergency Medical Services, Poznan, Poland Poznan University of Medical Sciences, Department of Palliative Medicine, Poznan, Poland ZF RTW, Częstochowa, Poland Hunter Holmes McGuire VA Medical Center, Department of Surgery, Richmond, United States of America Lublin Medical University, Lublin, Poland


PLOS ONE | 2013

Endovascular Treatment of Late Thoracic Aortic Aneurysms after Surgical Repair of Congenital Aortic Coarctation in Childhood

Robert Juszkat; Bartłomiej Perek; Bartosz Zabicki; Olga Trojnarska; Marek Jemielity; Ryszard Staniszewski; Wiesław Smoczyk; Fryderyk Pukacki

Background In some patients, local surgery-related complications are diagnosed many years after surgery for aortic coarctation. The purposes of this study were: (1) to systematically evaluate asymptomatic adults after Dacron patch repair in childhood, (2) to estimate the formation rate of secondary thoracic aortic aneurysms (TAAs) and (3) to assess outcomes after intravascular treatment for TAAs. Methods This study involved 37 asymptomatic patients (26 female and 11 male) who underwent surgical repair of aortic coarctation in the childhood. After they had reached adolescence, patients with secondary TAAs were referred to endovascular repair. Results Follow-up studies revealed TAA in seven cases (19%) (including six with the gothic type of the aortic arch) and mild recoarctation in other six (16%). Six of the TAA patients were treated with stentgrafts, but one refused to undergo an endovascular procedure. In three cases, stengrafts covered the left subclavian artery (LSA), in another the graft was implanted distally to the LSA. In two individuals, elective hybrid procedures were performed with surgical bypass to the supraaortic arteries followed by stengraft implantation. All subjects survived the secondary procedures. One patient developed type Ia endoleak after stentgraft implantation that was eventually treated with a debranching procedure. Conclusions The long-term course of clinically asymptomatic patients after coarctation patch repair is not uncommonly complicated by formation of TAAs (particularly in individuals with the gothic pattern of the aortic arch) that can be treated effectively with stentgrafts. However, in some patients hybrid procedures may be necessary.

Collaboration


Dive into the Bartłomiej Perek's collaboration.

Top Co-Authors

Avatar

Marek Jemielity

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Robert Juszkat

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Mateusz Puślecki

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Michał Nowicki

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Piotr Buczkowski

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Sebastian Stefaniak

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Agnieszka Malinska

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Marcin Ligowski

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Marcin Misterski

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Anna Perek

Poznan University of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge